skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
12670360
Filing Dt:
02/10/2010
Publication #:
Pub Dt:
06/03/2010
Inventors:
William G. Kerr, Amy Hazen
Title:
Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis
Assignment: 1
Reel/Frame:
023924/0070Recorded: 02/11/2010Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/26/2010
Exec Dt:
02/03/2010
Assignee:
3802 SPECTRUM BLVD., SUITE 100
TAMPA, FLORIDA 33612-9220
Correspondent:
GLENN P. LADWIG
P.O. BOX 142950
GAINESVILLE, FL 32614-2950
Assignment: 2
Reel/Frame:
025441/0627Recorded: 12/03/2010Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/03/2010
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 3
Reel/Frame:
034979/0573Recorded: 02/12/2015Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/03/2010
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/06/2024 02:13 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT